{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-005957","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2025-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.212717+00:00","generated_at":"2026-05-27T15:37:45.180650+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bellevue Life Sciences extends sponsor promissory notes maturity to Sept 30, 2025 regardless of business combination","bullets":["Second amendment removes earlier condition that notes matured on earlier of Sept 30, 2025 or business combination close.","Four promissory notes from sponsor Bellevue Global Life Sciences Investors, LLC aggregate $1.69M principal.","All other terms remain unchanged; notes are unsecured and governed by existing covenants.","Amendment executed January 23, 2025; previous amendment dated January 9, 2025 extended to Sept 30, 2025 or deal."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-005957","json":"https://secwatch.observer/filing/0001213900-25-005957.json","markdown":"https://secwatch.observer/filing/0001213900-25-005957.md","text":"https://secwatch.observer/filing/0001213900-25-005957.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000121390025005957/0001213900-25-005957-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000121390025005957/ea0228426-8k_bellevue.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T15:37:45.180650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}